Skip to main content
. 2013 Jan;93(1):161–170. doi: 10.1189/jlb.0612301

Figure 2. Changes in cytokine expression in HCs and CLL/SLL patients stratified according to cytogenetic risk.

Figure 2.

FCs escalate from HCs to GR CLL/SLL to int/PR CLL/SLL for IL-10 (A) and sIL-2Rα (C) but de-escalate for IL-17 (B), IL-23 (D), IL-9 (E), and IL-33 (F) with statistical significance using two-sample t-tests. In the CLL population, a trend for escalation in IL-5 (G) and IL-13 (I) and a trend for de-escalation in IL-12(p70) (H) and IFN-γ (J) are also seen.